Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Spada

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Endocrine-Related Cancer|June 16, 2026
The NET Score: An Interpretable AI-Assisted Prognostic Score for Mortality Risk in Lung Neuroendocrine TumorsLuca Bertolaccini, Francesca Spada, Lavinia Benini, et al.
Surgery|March 4, 2014
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approachEmilio Bertani, Nicola Fazio, Edoardo Botteri, et al.
Neuroendocrinology|September 11, 2015
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control StudyMaria Rinzivillo, Gabriele Capurso, Davide Campana, et al.
Cancer Treatment Reviews|December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasNicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Journal for Immunotherapy of Cancer|May 23, 2024
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?Lorenzo Gervaso, Davide Ciardiello, Rivadavio Antunes Oliveira, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) TherapyJasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, et al.
Journal of Endocrinological Investigation|February 24, 2024
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapyFrancesca Spada, Massimo Milione, Patrick Maisonneuve, et al.
Journal for Immunotherapy of Cancer|June 14, 2022
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panelFrancesca Spada, Paolo Bossi, Corrado Caracò, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Endocrine-Related Cancer|June 16, 2026
The NET Score: An Interpretable AI-Assisted Prognostic Score for Mortality Risk in Lung Neuroendocrine TumorsLuca Bertolaccini, Francesca Spada, Lavinia Benini, et al.
Surgery|March 4, 2014
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approachEmilio Bertani, Nicola Fazio, Edoardo Botteri, et al.
Neuroendocrinology|September 11, 2015
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control StudyMaria Rinzivillo, Gabriele Capurso, Davide Campana, et al.
Cancer Treatment Reviews|December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasNicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Journal for Immunotherapy of Cancer|May 23, 2024
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?Lorenzo Gervaso, Davide Ciardiello, Rivadavio Antunes Oliveira, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) TherapyJasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, et al.
Journal of Endocrinological Investigation|February 24, 2024
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapyFrancesca Spada, Massimo Milione, Patrick Maisonneuve, et al.
Journal for Immunotherapy of Cancer|June 14, 2022
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panelFrancesca Spada, Paolo Bossi, Corrado Caracò, et al.
Pageof 12